Close Menu

NEW YORK – Illumina announced Monday the funding of nine companies as part of its accelerator programs in the US and the UK.

During the six-month funding cycle, the participants will receive an undisclosed amount of seed investment, access to Illumina sequencing systems and reagents, and lab space adjacent to Illumina's Bay Area and Cambridge, UK campuses, respectively, as well as access to guidance and expertise.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.